Upashita Intravenous Injection for Dialysis 100μg Syringe, manufactured by Sanwa Chemical Research Institute, contains Upacicalcet sodium hydrate. This calcimimetic agent works by increasing the sensitivity of calcium-sensing receptors on the parathyroid glands to help manage secondary hyperparathyroidism in patients undergoing hemodialysis. It is available as a 100μg/1mL/1 tube injectable drug (YJ code: 3999460G3024).
Upashita Intravenous Injection for Dialysis 100μg Syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →